January 30, 2019
Study Assessing Double-masked Uveitis Treatment
Read More
January 30, 2019
SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection
Read More
January 30, 2019
SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection
Read More
January 30, 2019
Telaprevir in Genotype 3 HCV
Read More
January 30, 2019
Telaprevir in Genotype 3 HCV
Read More
January 30, 2019
A Study to Evaluate Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection, With APRI (a Predictor of Hepatic Fibrosis) ≤ 1, and Have Never Received HCV Treatment
Read More
December 10, 2018
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
Read More
December 10, 2018
Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy
Read More
December 10, 2018
International Guillain-Barré Syndrome Outcome Study
Read More
December 10, 2018
Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure
Read More
December 10, 2018
Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency
Read More
X